Mark W. Redrow, MD works in the field of Oncology. He received awards:"Meaningful Use Stage 1 Certification" and "Super Doctor". Mark W. Redrow, MD has written publications. He has 2 publications published with PubMed. The lastest publication is: 'Dialysis in the management of pregnant patients with renal insufficiency.' He is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1689615726 | |
NPPES Provider LastName | REDROW | |
NPPES Provider FirstName | MARK | |
NPPES Provider ZIPCode | 761043926 | |
NPPES Provider State | TX | |
Specialty Description | Medical Oncology | |
Total Claim Count | 2365.0 | |
Distinct Opioid Count | 10.0 | |
Opioid Claim Count | 527.0 | |
Percent Opioid Claims | 22.28 |
National Provider Identifier [NPI] | 1689615726 |
Last Name Of The Provider | REDROW |
First Name Of The Provider | MARK |
View All |
![]() |
Dr. Asad Dean, MD
![]() |
![]() |
Dr. Stephen L. Richey, MD
![]() ![]() |
![]() |
Dr. Randall D. Crim, MD |
![]() |
Dr. William M. Jordan, DO |
![]() |
Dr. John L. Nugent, MD
![]() |
![]() |
Dr. Robert L. Ruxer Jr., MD
![]() ![]() |
![]() |
Dr. Latha S. Neerukonda, MD
![]() |